Autocrine stimulation in colorectal carcinoma (CRC): Positive autocrine loops in human colorectal carcinoma and applicable significance of blocking the loops

Medical Oncology

Volumn 21, Issue 1, 2004, Pages 1-7

  Ruan, Wen Jing ^a   Lai, Mao De ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autocrine loops; Colorectal carcinoma; Prognostic markers; Therapeutic targets

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRYPSIN;

CANCER CELL; CELL GROWTH; COLORECTAL CARCINOMA; DISEASE COURSE; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; REVIEW; STIMULATION;

EID: 1842833447     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/mo:21:1:01     Document Type: Review

References (29)

1. Eisenhauer EA. From the molecule to the clinic - inhibiting HER2 to treat breast cancer. N Engl J Med 2001; 344:841-842.
2. al-Azzawi F, Wahab M. Estrogen and colon cancer: current issues. Climacteric 2002; 5:3-14.
3. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N Engl J Med 1980; 303:878-880.
4. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313:745-747.
5. Huang SA, et al. Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene. J Cell Physiol 1991; 148:220-227.
6. Jiang D, et al. Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. J Biol Chem 1998; 273:31471-31479.
7. Johnson GR, et al. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol 1992; 118:741-751.
8. Venkateswarlu S, et al. Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene 2002; 21:78-86.
9. Huang F, Newman E, Theodorescu D, Kerbel RS, Friedman E. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Cell Growth Differ 1995; 6:1635-1642.
10. Baghdiguian S, Verrier B, Gerard C, Fantini J. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth. Cancer Lett 1992; 62:23-33.
11. Lamonerie T, Lavialle C, Haddada H, Brison O. IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 1995; 61:587-592.
12. Lamonerie T, Lavialle C, de Galle B, Binoux M, Brison O. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res 1995; 216:342-351.
13. New BA, Yeoman LC. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J Cell Physiol 1992; 150:320-326.
14. Lahm H, et al. Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Differ 1995; 6:1111-1118.
15. Hoosein NM, Kiener PA, Curry RC, Brattain MG. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin- like peptide. Exp Cell Res 1990; 186:15-21.
16. Wu P, et al. Gastrin stimulated growth of colorecal carcinoma. World Chin J Digestol 1999; 7:501-503.
17. Rosenberg IM, Goke M, Kanai M, Reinecker HC, Podolsky DK. Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am J Physiol 1997; 273:6824-832.
18. Brew R, et al. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000; 12:78-85.
19. Ducroc R, et al. Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop. Life Sci 2002; 70:1359-1367.
20. Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 2001; 85:772-779.
21. Lahm H, et al. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 1992; 65:341-346.
22. Wang D, et al. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Oncogene 2002; 21:2785-2796.
23. Howell GM, et al. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop. J Cell Physiol 1995; 162:256-265.
24. Bellone G, et al. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol 1997; 172:1-11.
25. Zvibel I, Brill S, Halpern Z, Papa M. Amphiregulin and hepatocyte-derived extracellular matric regulate proliferation and autocrine growth factor expression in colon cancer cell lines of varying liver-colonizing capability. J Cell Biochem 1999; 76:332-340.
26. Barozzi C, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panle. Cancer 2002; 94:647-657.
27. Watson SA, et al. Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5. Int J Cancer 1995; 61:233-240.
28. Williams KJ, Telfer BA, Stratford IJ, Wedge SR. ZD 1839 ("Iressa"), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br J Cancer 2002; 86:1157-1161.
29. Adachi Y, et al. Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines. Gastroenterology 2002; 123:1191-1204.